ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
China's latest bid to spur new drugs? A tax cut for rare disease treatments
February 24, 2019Playing catch-up in the orphan drug field, China will cut the value-added tax rate for some rare-disease therapies by more than 80% in an effort to get new treatments to market faster. And multinational drugmakers are most likely to reap the benefits.
Pharma Sources Insight January 2025
